Skip to main content
S&P 5007,637.76+1.14%DOW51,778.04+0.61%NASDAQ26,418.30+1.69%BTC$76,416.00+0.10%ETH$2,442.29+0.95%GOLD$4,397.70-0.05%OIL$100.86-1.03%
Smart Investors Daily
Ligand Pharmaceuticals, Inc. logo

OTC · LGNDZ

Ligand Pharmaceuticals, Inc.

Healthcare · Medical - Pharmaceuticals

$0.00

Up+$0.00 (+33.88%)

Updated Sep 18, 2026, 6:45 AM

SID Score

3.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
157.46K
P/E ratio
99
Dividend yield
0.00%
52-week range
$0.00 – $0.02
Volume
4.51K
Avg. volume
56.76K

Price performance

LGNDZ price history

1M range · 5 trading sessions · Daily adjusted prices

LGNDZ closed at $0.00 after 5 trading sessions, up 42.25% for the selected period.

Last close
$0.00
Period change
+42.25%
Period low
$0.00
Period high
$0.00
Daily close
View OHLC price history
LGNDZ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 16, 2026$0.0023$0.0023$0.0023$0.00234.51K
Sep 10, 2026$0.0017$0.0017$0.0017$0.00175K
Sep 8, 2026$0.002$0.002$0.002$0.00220K
Aug 28, 2026$0.0019$0.0019$0.0019$0.0019307.85K
Aug 20, 2026$0.0013$0.0016$0.0013$0.001610.1K

Latest LGNDZ news

The latest Smart Investors Daily articles mentioning LGNDZ.

Stock researchCompany · Overview

LGNDZ research

Overview

Company profile and research snapshot.

Company profile

LIGAND PHARMS INC CVR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
13
LGNDZ recent ratings
DateFirmRatingTarget
Aug 14, 2026Leerink PartnersOutperform—
Aug 7, 2026RBC CapitalOutperform—
Aug 6, 2026HC Wainwright & Co.Buy—
Aug 3, 2026OppenheimerOutperform—
Jul 21, 2026CitigroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By